FDA Inspection 812027 — Fisher Wallace Laboratories Inc.

Fisher Wallace Laboratories Inc. — FEI 3006258094

The FDA completed an inspection of Fisher Wallace Laboratories Inc. on Dec 20, 2012 in Brooklyn, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 20, 2012
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Brooklyn, NY (United States)

Citations

IDCFRDescription
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
310421 CFR 820.30(j)Design history file
313021 CFR 820.100(a)Lack of or inadequate procedures
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.